Davide Campari-Milano stock forecast: Third-party price targets
Davide Campari-Milano shares are closely watched as investors assess brand performance, strategic changes and broader equity market sentiment across the European consumer sector. Explore CPR’s price action, third-party price targets and technical analysis.
Davide Campari-Milano (CPR) is trading around €5.80 in early European dealings on 16 January 2026 as of 12:04pm (UTC), with the price moving between an intraday low of €5.58 and a high of €5.89 on Capital.com’s EUR-denominated stock CFD feed. Past performance is not a reliable indicator of future results.
The stock is trading amid ongoing attention to Campari Group’s portfolio streamlining and balance-sheet initiatives, including recent disposals of smaller liqueur brands (Reuters, 16 December 2025) and an earlier exit from its Tannico e-commerce joint venture, as the group looks to concentrate on core labels and improve returns (MarketScreener, 6 October 2026). Investor focus also remains on the company’s longer-term strategy to simplify its brand portfolio and expand geographically, outlined at its 2025 strategy day (Reuters, 7 November 2025), set against broader European equity sentiment, with major regional indices recently supported by gains in technology-related names (STOXX, 6 November 2025).
Campari stock forecast 2026–2030: Third-party price targets
As of 16 January 2026, third-party Davide Campari-Milano stock predictions indicate expected 12-month price levels modestly above the current Capital.com last price of €5.80. These figures are typically framed as indicative 12-month objectives rather than fixed year-end levels, and they depend on assumptions around earnings, valuation multiples and wider market conditions, all of which can change over time.
MarketScreener (consensus overview)
MarketScreener’s consensus page for CPR stock forecasts indicates an average analyst target of around €6.86, based on a compiled set of broker models. The service notes that this implied upside reflects the gap between the current market price and aggregated objective prices, within a mix of buy, hold and sell recommendations across covering analysts (MarketScreener, 14 January 2026).
Fintel (broker target aggregation)
Fintel reports an average one-year price target of €7.05 for Davide Campari-Milano N.V., with forecasts ranging from a low of €4.24 to a high of €11.55. The platform explains that these targets represent where analysts consider the stock fairly valued relative to projected and historical earnings, with estimates updated on a rolling basis as new research becomes available (Fintel, 16 January 2026).
TradingView (analyst target compilation)
TradingView’s forecast page for CPR states that, according to analysts, the one-year price target is about €6.91, with a maximum estimate of €11 and a minimum of €4.20. The platform highlights that these targets summarise views from 21 analysts over the preceding three months, with revisions influenced by earnings updates and macroeconomic expectations (TradingView, 16 January 2026).
Investing.com (CPR target range)
Investing.com’s Campari page reports an average 12-month price target of approximately €6.86, based on coverage of the Milan-listed shares and data available into early 2026. The site adds that analysts are split between buy and hold ratings, as they weigh brand strength and margin prospects against valuation and competitive pressures within the spirits sector (Investing.com, 16 January 2026).
Predictions and third-party forecasts are inherently uncertain, as they cannot fully account for unexpected market developments. Past performance is not a reliable indicator of future results.
CPR stock price: Technical overview
The CPR stock price is trading around €5.80 on 16 January 2026, holding above its near-term moving-average cluster, with the 20-, 50-, 100- and 200-day simple moving averages (SMAs) positioned roughly around €5.67, €5.73, €5.76 and €5.85 respectively. The 14-day RSI near 59 sits in the upper-neutral zone, while an ADX reading just below 12 points to a weak underlying trend, consistent with price action that appears more range-bound than directional. Shorter-term measures, including the 10- and 30-day SMAs and EMAs, are grouped close to the current price, keeping CPR confined within a relatively narrow technical band.
On the topside, the nearest classic pivot resistance lies at €5.98, with a sustained daily close above that level potentially bringing the €6.42 R2 area into focus as the next upside reference. On pullbacks, initial support is marked by the €5.71 pivot, while the 200-day SMA near €5.85 and the 100-day SMA around €5.76 form a nearby moving-average zone. A clear break below this area could open the way towards the €5.27 S1 level (TradingView, 16 January 2026).
This technical analysis is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any instrument.
Campari share price history (2024–2026)
CPR’s stock price has spent much of the past two years oscillating within a relatively contained range, mostly between about €5.20 and €6.70, rather than establishing a sustained breakout in either direction. The stock ended 2024 near €6.29 on 6 December before easing back in early 2025, with several dips towards the mid-€5s, followed by advances to peaks around €6.41 in March and €6.71 in August as volatility picked up.
From late August 2025, when the price traded above €6.70, momentum cooled. CPR gradually slipped lower, closing around €6.07 at the end of October before drifting into the €5.50–€5.90 range through November and December. As of 16 January 2026, the share closed at €5.83, leaving it modestly below levels seen a year earlier, but still well within the multi-year range that has characterised much of its recent history.
Past performance is not a reliable indicator of future results.
Campari (CPR): Capital.com analyst view
Davide Campari-Milano’s share price over the past year has largely moved within a moderate range, with periods of strength around €6.50–€6.80 giving way to more recent trading closer to €5.80 as of 16 January 2026. Company updates indicate resilient underlying performance, with Campari Group reporting organic net sales growth of 1.5% for the first nine months of 2025 and pointing to continued brand momentum, which may support sentiment when markets focus on execution and profitability rather than short-term volatility.
At the same time, management has highlighted pressure on European consumers and a challenging operating environment. Third-party analysis also points to above-average share price volatility relative to parts of the Italian market, meaning that setbacks in earnings, foreign-exchange movements or broader risk appetite could weigh on the stock as readily as positive developments could support it. Sector indices, such as Euro Stoxx food and beverage benchmarks, have shown mixed performance, so shifts in rates, growth expectations or investor sentiment can influence CPR alongside peers, rather than moves being driven solely by company-specific factors.
Summary – Campari 2026
- Davide Campari-Milano (CPR) trades around €5.80 as of 16 January 2026, within a two-year range that has largely spanned approximately €5.20–€6.80.
- The share closed 2024 near €6.29 and subsequently eased, with 2025 marked by swings towards €6.70 in August before drifting into the €5.50–€6.00 area by year-end.
- Technical indicators show CPR holding near a cluster of short- and medium-term moving averages around €5.70–€5.85, with RSI in upper-neutral territory and ADX pointing to a weak trend.
- Company results reported so far for 2025 suggest resilient organic sales growth despite a challenging backdrop, which may help underpin sentiment during periods of stable market conditions.
Past performance is not a reliable indicator of future results.
FAQ
Who owns the most Campari stock?
Davide Campari-Milano is a widely held public company, with its largest shareholding controlled by the Garavoglia family through holding vehicles linked to Lagfin S.C.A. This structure gives the founding family meaningful influence over long-term strategy and governance. The remaining shares are spread across institutional investors, funds and retail shareholders, reflecting the group’s long-standing inclusion in European equity indices and a diversified investor base.
What is the 5-year Campari share price forecast?
There are no single, reliable five-year CPR stock forecasts. Most publicly available analyst estimates focus on 12-month horizons and are updated frequently as earnings, macroeconomic conditions and sector trends evolve. Longer-term projections tend to rely on assumptions about brand performance, geographic expansion and margins, all of which may shift over time. As a result, extended forecasts are generally viewed as illustrative scenarios rather than precise expectations.
Is Campari a good stock to buy?
Whether Campari is considered a 'good' stock depends on an individual’s objectives, risk tolerance and market outlook. Analysts often highlight the group’s established brands and global footprint, while also noting valuation considerations, consumer demand trends and competitive pressures within the spirits sector. Share price performance can reflect both supportive developments and adverse factors, meaning assessments vary over time and across market participants rather than pointing to a single, definitive conclusion.
Could Campari stock go up or down?
Campari’s share price can move both higher and lower, influenced by company-specific factors such as earnings updates, brand performance and strategic decisions, alongside broader market forces. Changes in consumer spending, input costs, foreign exchange rates and overall equity sentiment can all affect pricing. While the stock has often traded within defined ranges in recent years, periods of increased volatility can still occur as new information is absorbed.
Should I invest in Campari stock?
This article does not provide investment advice or recommendations. Deciding whether to invest in Campari stock involves considering personal financial circumstances, risk appetite and investment horizon. Investors commonly review factors such as financial performance, sector conditions and diversification within a broader portfolio. Given that share prices can fluctuate and forecasts may change, many market participants also weigh the potential for both gains and losses before making any investment decision.
Can I trade Campari CFDs on Capital.com?
Yes, you can trade Davide Campari-Milano CFDs on Capital.com. Trading share CFDs lets you speculate on price movements without owning the underlying asset and to take long or short positions. However, contracts for difference (CFDs) are traded on margin, and leverage amplifies both profits and losses. You should ensure you understand how CFD trading works, assess your risk tolerance, and recognise that losses can occur quickly.